# OnCo record netris-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/netris-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "netris-pharma" ;
  schema:name "Netris Pharma"@en ;
  schema:alternateName "NETRIS Pharma SAS"@en ;
  schema:description "Netris Pharma is a Lyon biotech built on Patrick Mehlen's discovery that tumours use the guidance protein netrin-1 to survive; its antibody NP137 blocks netrin-1 and has shown activity in endometrial cancer."@en ;
  schema:url <https://onco.cc/companies/netris-pharma/>, <https://www.netrispharma.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.netrispharma.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "FR" ;
  onco:drugs <https://onco.cc/drugs/np137/> .